title: Safety and technique of ferumoxytol administration for MRI.
abstract: Ferumoxytol is an ultrasmall superparamagnetic iron oxide agent marketed for the treatment of anemia. There has been increasing interest in its properties as an MRI contrast agent as well as greater awareness of its adverse event profile. This mini-review summarizes the current state of knowledge of the risks of ferumoxytol and methods of administration.
authors.affiliation: Department of Radiology, Stanford University, Stanford, CA.
authors.forename: Shreyas S
authors.initials: SS
authors.lastname: Vasanawala
authors.affiliation: Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles.
authors.forename: Kim-Lien
authors.initials: KL
authors.lastname: Nguyen
authors.affiliation: Department of Radiology, University of California, San Francisco.
authors.forename: Michael D
authors.initials: MD
authors.lastname: Hope
authors.affiliation: Department of Radiology, Mayo Clinic Florida, Jacksonville, FL.
authors.forename: Mellena D
authors.initials: MD
authors.lastname: Bridges
authors.affiliation: Department of Radiology, University of California, San Francisco.
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Hope
authors.affiliation: Departments of Radiology, Medical Physics, Biomedical Engineering, and Emergency Medicine, University of Wisconsin, Madison, WI.
authors.forename: Scott B
authors.initials: SB
authors.lastname: Reeder
authors.affiliation: Center for Advanced Magnetic Resonance Development and Department of Radiology, Duke University, Durham, NC.
authors.forename: Mustafa R
authors.initials: MR
authors.lastname: Bashir
mesh_terms: D002986:Clinical Trials as Topic; D003287:Contrast Media / Q000737:chemistry; D005290:Ferric Compounds / Q000737:chemistry; D052203:Ferrosoferric Oxide / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D005682:Gadolinium / Q000737:chemistry; D006801:Humans; D007455:Iodine / Q000737:chemistry; D008264:Macrophages / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*; D061214:Patient Safety; D010477:Perfusion
chemical_list: D003287:Contrast Media; D005290:Ferric Compounds; C000499:ferric oxide; D007455:Iodine; D005682:Gadolinium; D052203:Ferrosoferric Oxide
keywords: contrast agent; ferumoxytol; iron oxide; safety